CN114432395A - 一种用于女性阴道清洁护理凝胶的制备方法 - Google Patents
一种用于女性阴道清洁护理凝胶的制备方法 Download PDFInfo
- Publication number
- CN114432395A CN114432395A CN202210147083.1A CN202210147083A CN114432395A CN 114432395 A CN114432395 A CN 114432395A CN 202210147083 A CN202210147083 A CN 202210147083A CN 114432395 A CN114432395 A CN 114432395A
- Authority
- CN
- China
- Prior art keywords
- extract
- gel
- cleaning
- nursing
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001215 vagina Anatomy 0.000 title claims abstract description 28
- 230000000474 nursing effect Effects 0.000 title claims abstract description 25
- 238000004140 cleaning Methods 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 57
- 210000000265 leukocyte Anatomy 0.000 claims abstract description 14
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 11
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 11
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 11
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 8
- 241000972672 Phellodendron Species 0.000 claims abstract description 8
- 244000173853 Sanguisorba officinalis Species 0.000 claims abstract description 8
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 8
- 229940069521 aloe extract Drugs 0.000 claims abstract description 8
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 7
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 7
- FZAQROFXYZPAKI-UHFFFAOYSA-N anthracene-2-sulfonyl chloride Chemical compound C1=CC=CC2=CC3=CC(S(=O)(=O)Cl)=CC=C3C=C21 FZAQROFXYZPAKI-UHFFFAOYSA-N 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000008213 purified water Substances 0.000 claims abstract description 6
- 244000061520 Angelica archangelica Species 0.000 claims abstract 2
- 210000004027 cell Anatomy 0.000 claims description 15
- 239000001963 growth medium Substances 0.000 claims description 9
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 6
- 241000282414 Homo sapiens Species 0.000 claims description 5
- 102100037850 Interferon gamma Human genes 0.000 claims description 3
- 108010074328 Interferon-gamma Proteins 0.000 claims description 3
- 102000004125 Interleukin-1alpha Human genes 0.000 claims description 3
- 108010082786 Interleukin-1alpha Proteins 0.000 claims description 3
- 108010002350 Interleukin-2 Proteins 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 210000004698 lymphocyte Anatomy 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 210000005259 peripheral blood Anatomy 0.000 claims description 3
- 239000011886 peripheral blood Substances 0.000 claims description 3
- 230000035755 proliferation Effects 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 206010000210 abortion Diseases 0.000 abstract description 3
- 231100000176 abortion Toxicity 0.000 abstract description 3
- 230000000975 bioactive effect Effects 0.000 abstract description 3
- 230000003821 menstrual periods Effects 0.000 abstract description 3
- 230000001568 sexual effect Effects 0.000 abstract description 3
- 241000125175 Angelica Species 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000003756 cervix mucus Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000004483 Dyspareunia Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 2
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- -1 gelatinizer Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
Abstract
本发明属于护理用品技术领域，具体涉及一种用于女性阴道清洁护理凝胶的制备方法。一种用于女性阴道清洁护理凝胶，按重量百分比计由以下成分制备而成：白细胞提取物1‑5％、黄柏提取液2‑5％、丹参提取液2‑5％、地榆提取液2‑5％、苦参提取液2‑5％、当归提取液5‑10％、芦荟提取液5‑20％、β‑烟酰胺单核苷酸2‑5％、高分子透明质酸15‑20％，余量为纯化水。本发明的清洁护理凝胶由生物活性成分和中药草本精华制成，区别于传统女性阴道凝胶，用于清洁护理女性阴道时安全高效，可以修复阴道环境，排出因性生活、人流和经期等残留垃圾，充分发挥清理护理，抑菌滋养和紧致呵护的效果。
Description
技术领域
本发明属于护理用品技术领域，具体涉及一种用于女性阴道清洁护理凝胶的制备方法。
背景技术
阴道干涩是指阴道分泌物显著减少使阴道干燥，多由于年龄、压力、激素异常和炎症刺激等因素引起，为绝经期女性好发，伴有性交痛、外因瘙痒和外阴萎缩等现象。引起阴道干涩的原因比较多，主要包括内分泌失调、阴道炎和过度清洁，另外，饮食不均衡和干燥综合征等也可导致阴道干涩。
常规阴道护理凝胶大多为化学有机溶剂和抑菌剂混合制成，其虽然能在一定程度上解决阴道内壁的缺水及炎症，但一旦停用极易复发，治标不治本，而且长期或频繁使用还会对阴道粘膜造成极大伤害。
公开于该背景技术部分的信息仅仅旨在增加对本发明的总体背景的理解，而不应当被视为承认或以任何形式暗示该信息构成已为本领域一般技术人员所公知的现有技术。
发明内容
本发明的目的在于提供一种用于女性阴道清洁护理凝胶的制备方法，以解决背景技术中现有阴道护理凝胶存在的问题。
为实现上述目的，本发明提供了如下技术方案：
一种用于女性阴道清洁护理凝胶，按重量百分比计由以下成分制备而成：白细胞提取物1-5％、黄柏提取液2-5％、丹参提取液2-5％、地榆提取液2-5％、苦参提取液2-5％、当归提取液5-10％、芦荟提取液5-20％、β-烟酰胺单核苷酸2-5％、高分子透明质酸15-20％，余量为纯化水。
作为优选，所述白细胞提取物的制备方法包括以下步骤：
S1.取人外周血50-60mL，用淋巴细胞分离液密度梯度分离法分离出外周血单个核细胞；
S2.用ALys50N-0培养基洗涤所得外周血单个核细胞一次；
S3.用ALys50N-0培养基调整细胞浓度至1-2×106个/mL后置于T175培养瓶中，转移至培养箱中培养；
S4.2h后将T175培养瓶取出，取另一个T175培养瓶将悬浮细胞收集，加入1000IU/mL IFN-γ培养；
S5.24h后添加50ng/mL抗CD3单克隆抗体、1000IU/mL IL-2和100IU/mL IL-1α进行增殖培养；
S6.每2-3d添加一倍的ALys50N-0培养基，14d后收集细胞悬浮液进行冷冻干燥，获得白细胞提取物。
作为优选，所述女性阴道清洁护理凝胶制备方法为：按重量百分比计取各成分，震荡混匀即可。
与现有技术相比，本发明具有如下有益效果：
本发明凝胶制备原料中白细胞提取物富含40余种生物活性成分，可通过修复受损细胞，帮助肌肤产生胶原蛋白与弹力纤维，强化肌肤内部支撑结构，激活基底细胞，让细胞自我新生；同时可加速和促进肌肤微循环的建立，加速新陈代谢，促使肌肤自行排出毒素，从而全面提升肌肤状态，延缓皮肤衰老。
黄柏提取物主治功效：湿疹瘙痒，滋阴降火。用于阴虚火旺，盗汗骨蒸。
丹参提取物主治功效：抗感染，用于化脓性和外科感染，用于治疗宫颈糜烂。
地榆提取物主治功效：调节和改善机体免疫功能
苦参提取物主治功效：性寒，有清热燥湿和杀虫的功效，苦参浴能够清除下焦湿热，并且杀虫止痒，对皮肤瘙痒有很好的缓解作用，植物中草药能够平衡油脂分泌，疏通并收敛毛孔，清除皮肤内毒素杂质，丰富的本草营养，促进受损血管神经细胞的生长和修复，恢复皮下毛细血管细胞活力，肌肤重现紧致细滑
当归提取物主治功效：当归提取物是一种用于补血活血，调经止痛，润肠通便，血虚萎黄，眩晕心悸，月经不调，经闭痛经，虚寒腹痛，肠燥便秘，风湿痹痛，跌扑损伤，痈疽疮疡的植物提取物。
芦荟提取物可用作增稠剂、稳定剂、胶凝剂、粘结剂，用于一般食品。也用于化妆品等中：芦荟的蒽醌类化合物具有使皮肤收敛、柔软化、保湿、消炎、漂白的性能。还有解除硬化、角化、改善伤痕的作用，不仅能防止小皱纹、眼袋、皮肤松弛，还能保持皮肤湿润、娇嫩，同时，还可以治疗皮肤炎症。
烟酰胺单核苷酸在人体细胞能量生成中扮演重要角色，它参与细胞内NAD(烟酰胺腺嘌呤二核苷酸，细胞能量转化的重要辅酶)的合成。
透明质酸是一种多功能基质，广泛分布于人体各部位，其中皮肤也含有大量的透明质酸。人类皮肤成熟和老化过程也随着透明质酸的含量和新陈代谢而变化，它可以改善皮肤营养代谢，使皮肤柔嫩、光滑、去皱、增加弹性、防止衰老，在保湿的同时又是良好的透皮吸收促进剂，与其他营养成分配合使用，可以起到促进营养吸收的更理想效果。
本发明的清洁护理凝胶由以上生物活性成分和中药草本精华制成，区别于传统女性阴道凝胶，用于清洁护理女性阴道时安全高效，可以修复阴道环境，排出因性生活、人流和经期等残留垃圾，充分发挥清理护理，抑菌滋养和紧致呵护的效果。
具体实施方式
下面结合对本发明专利的技术方案进行清楚、完整的描述，显然，所描述的实施例是本发明的一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域所属的技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
在以下实施例中，黄柏提取液、丹参提取液、地榆提取液、苦参提取液、当归提取液、芦荟提取液和高分子透明质酸购置于广州美懿生物科技有限公司，其中高分子透明质酸分子量为1800000-2200000。β-烟酰胺单核苷酸购置于吉林百奥生物科技有限公司。
实施例1
白细胞提取物的制备方法，包括以下步骤：
S1.取人外周血50-60mL，用淋巴细胞分离液密度梯度分离法分离出外周血单个核细胞；
S2.用ALys50N-0培养基洗涤所得外周血单个核细胞一次，此时外周血单个核细胞的数量需为3-5×107个；
S3.用ALys50N-0培养基调整细胞浓度至1-2×106个/mL后置于T175培养瓶中，转移至培养箱中培养；
S4.2h后将T175培养瓶取出，取另一个T175培养瓶将悬浮细胞收集，加入1000IU/mL IFN-γ培养；
S5.24h后添加50ng/mL抗CD3单克隆抗体、1000IU/mL IL-2和100IU/mL IL-1α进行增殖培养；
S6.每2-3d添加一倍的ALys50N-0培养基，14d后收集细胞悬浮液进行冷冻干燥，获得白细胞提取物。
于第0d和第14d取样做细胞流式检测，结果见表1。
表1 细胞流式检测结果
| CD3+CD56+(％) | CD3+CD8+(％) | 细胞成活率(％) | 细胞数量(个) | |
| 第0d | 11.2 | 19.6 | 98.1 | 7.5×107 |
| 第14d | 54.1 | 82.6 | 98.7 | 7.1×109 |
从表1可知，采用本发明的培养方法培养细胞14d后，CD3+CD56+、CD3+CD8+以及细胞数量均明显增加，同时细胞成活率也维持一个较高水平。
实施例2
一种用于女性阴道清洁护理凝胶，按重量百分比计由以下成分制备而成：白细胞提取物1％、黄柏提取液2％、丹参提取液3％、地榆提取液2％、苦参提取液3％、当归提取液6％、芦荟提取液8％、β-烟酰胺单核苷酸4％、高分子透明质酸17％，余量为纯化水。
实施例3
一种用于女性阴道清洁护理凝胶，按重量百分比计由以下成分制备而成：白细胞提取物2.5％、黄柏提取液4％、丹参提取液3％、地榆提取液3.5％、苦参提取液4％、当归提取液8％、芦荟提取液12％、β-烟酰胺单核苷酸3％、高分子透明质酸17％，余量为纯化水。
实施例4
一种用于女性阴道清洁护理凝胶，按重量百分比计由以下成分制备而成：白细胞提取物5％、黄柏提取液4％、丹参提取液3％、地榆提取液3％、苦参提取液5％、当归提取液9％、芦荟提取液18％、β-烟酰胺单核苷酸4％、高分子透明质酸18％，余量为纯化水。
上述实施例2-4中白细胞提取物由实施例1中的白细胞提取物的制备方法制备得到。
对比例1
与实施例3相比区别仅在于：缺少白细胞提取物。
使用者体验
200例试用者：年龄40-60岁，参照《临床诊疗指南-妇产科学分册》诊断标准，临床表现为：阴道分泌物增多；外阴瘙痒、灼热感，可伴有性交痛。将试用者随机分为2组：试验组和对照组，每组100人；其中试验组使用实施例3的凝胶，对照组使用对比例1的凝胶。
使用时，采取仰卧位，垫高臀部，将载有凝胶的凝胶器缓缓插入阴道内并退入阴道深处。使用完毕后保持卧位5-8min，避免凝胶过早流失。使用期间阴道内有正常排出物，需使用卫生护垫。于晚上睡觉前使用，隔天使用一次，连续使用4周，检测效果如表2。
表2 用于女性阴道清洁护理凝胶使用效果调查
从表2可以看出，试验组的使用者在阴道分泌物、瘙痒症状、同房紧致感和干涩感等方面均明显优于对照组，说明添加本发明的白细胞提取物可以有效提高凝胶的使用效果。
综上所述，本发明的凝胶可以修复阴道环境，排出因性生活、人流和经期等残留垃圾，充分发挥清理护理，抑菌滋养和紧致呵护的效果。
前述对本发明的具体示例性实施方案的描述是为了说明和例证的目的。这些描述并非想将本发明限定为所公开的精确形式，并且很显然，根据上述教导，可以进行很多改变和变化。对示例性实施例进行选择和描述的目的在于解释本发明的特定原理及其实际应用，从而使得本领域的技术人员能够实现并利用本发明的各种不同的示例性实施方案以及各种不同的选择和改变。本发明的范围意在由权利要求书及其等同形式所限定。
Claims (3)
1.一种用于女性阴道清洁护理凝胶，其特征在于，按重量百分比计由以下成分制备而成：白细胞提取物1-5％、黄柏提取液2-5％、丹参提取液2-5％、地榆提取液2-5％、苦参提取液2-5％、当归提取液5-10％、芦荟提取液5-20％、β-烟酰胺单核苷酸2-5％、高分子透明质酸15-20％，余量为纯化水。
2.根据权利要求1所述的用于女性阴道清洁护理凝胶，其特征在于，所述白细胞提取物的制备方法包括以下步骤：
S1.取人外周血50-60mL，用淋巴细胞分离液密度梯度分离法分离出外周血单个核细胞；
S2.用ALys50N-0培养基洗涤所得外周血单个核细胞一次；
S3.用ALys50N-0培养基调整细胞浓度至1-2×106个/mL后置于T175培养瓶中，转移至培养箱中培养；
S4.2h后将T175培养瓶取出，取另一个T175培养瓶将悬浮细胞收集，加入1000IU/mLIFN-γ培养；
S5.24h后添加50ng/mL抗CD3单克隆抗体、1000IU/mL IL-2和100IU/mL IL-1α进行增殖培养；
S6.每2-3d添加一倍的ALys50N-0培养基，14d后收集细胞悬浮液进行冷冻干燥，获得白细胞提取物。
3.根据权利要求1所述的用于女性阴道清洁护理凝胶，其特征在于，其制备方法为：按重量百分比计取各成分，震荡混匀，即得所述女性阴道清洁护理凝胶。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210147083.1A CN114432395A (zh) | 2022-02-14 | 2022-02-14 | 一种用于女性阴道清洁护理凝胶的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210147083.1A CN114432395A (zh) | 2022-02-14 | 2022-02-14 | 一种用于女性阴道清洁护理凝胶的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114432395A true CN114432395A (zh) | 2022-05-06 |
Family
ID=81373242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210147083.1A Pending CN114432395A (zh) | 2022-02-14 | 2022-02-14 | 一种用于女性阴道清洁护理凝胶的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114432395A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1377698A (zh) * | 2002-04-22 | 2002-11-06 | 武汉大学 | 纳米芦荟妇洁护理露及其制备方法 |
| CN101156873A (zh) * | 2007-10-16 | 2008-04-09 | 中山大学 | 一种来源于暹罗鳄白细胞抗菌活性物质及其制备方法 |
| CN105106304A (zh) * | 2015-08-18 | 2015-12-02 | 江苏丹晟生物科技有限公司 | 一种治疗妇科炎症的中药复方制剂及其制备方法 |
| CN107551090A (zh) * | 2017-09-18 | 2018-01-09 | 杨平芝 | 一种滋养修复凝胶 |
| CN107988155A (zh) * | 2017-12-06 | 2018-05-04 | 暨赛再生医学科技有限公司 | 一种cik细胞的制备方法 |
| CN113197944A (zh) * | 2021-05-17 | 2021-08-03 | 宁夏医科大学总医院 | 一种复方紫草微乳温敏原位凝胶及其制备方法和应用 |
-
2022
- 2022-02-14 CN CN202210147083.1A patent/CN114432395A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1377698A (zh) * | 2002-04-22 | 2002-11-06 | 武汉大学 | 纳米芦荟妇洁护理露及其制备方法 |
| CN101156873A (zh) * | 2007-10-16 | 2008-04-09 | 中山大学 | 一种来源于暹罗鳄白细胞抗菌活性物质及其制备方法 |
| CN105106304A (zh) * | 2015-08-18 | 2015-12-02 | 江苏丹晟生物科技有限公司 | 一种治疗妇科炎症的中药复方制剂及其制备方法 |
| CN107551090A (zh) * | 2017-09-18 | 2018-01-09 | 杨平芝 | 一种滋养修复凝胶 |
| CN107988155A (zh) * | 2017-12-06 | 2018-05-04 | 暨赛再生医学科技有限公司 | 一种cik细胞的制备方法 |
| CN113197944A (zh) * | 2021-05-17 | 2021-08-03 | 宁夏医科大学总医院 | 一种复方紫草微乳温敏原位凝胶及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1251763A (zh) | 中药复方制剂妇科千金片的配制方法 | |
| CN103920072A (zh) | 一种壳聚糖抗菌凝胶及其制备方法 | |
| CN112999261A (zh) | 一种舒缓动脉硬化的纳豆发酵组合物及其制备方法和应用 | |
| CN115607577B (zh) | 一种具有缓解口腔炎症功效的益生菌剂及其制备方法和应用 | |
| CN111632019A (zh) | 一种丝素蛋白美肌凝胶及其制备方法 | |
| CN111297961A (zh) | 一种促进伤口愈合的侗药 | |
| CN103157095A (zh) | 芸豆植物凝集素在制备人用药物中的应用及其药物组合物 | |
| CN113274414A (zh) | 一种修复和维持阴道微生态平衡的益生菌制剂 | |
| CN113575964A (zh) | 一种抗氧化和抗衰老的益生菌组合物及其制备方法 | |
| CN114432395A (zh) | 一种用于女性阴道清洁护理凝胶的制备方法 | |
| CN114908023B (zh) | 一株提高肠道放线菌门相对丰度、抑制促炎症因子表达量的凝结芽孢杆菌 | |
| CN104547644A (zh) | 一种褥疮膏 | |
| CN110151657B (zh) | 一种含有垂盆草提取物的祛痘凝胶及其制备方法 | |
| CN106581172B (zh) | 用于防治霉菌性、滴虫性和老年性阴道炎的药物及制备方法 | |
| CN110974935A (zh) | 一种含富勒烯c60成分的抑菌护理凝胶及其制备方法 | |
| CN107485655B (zh) | 桃花提取物在制备治疗前列腺炎药物中的应用 | |
| CN111658663A (zh) | 山麦冬皂苷b在制备用于治疗皮肤炎症药物中的应用 | |
| CN108685981A (zh) | 一种三七丹参胶囊及其制备方法 | |
| CN116726077B (zh) | 一种妇科外用洗液及其制备方法 | |
| CN102631497B (zh) | 一种保健组合物 | |
| CN111358888B (zh) | 一种用于治疗肺纤维化的中药组合物及其制备方法与用途 | |
| CN112972544B (zh) | 治疗烧烫伤和/或压疮的中药药膏及其制备方法和应用 | |
| CN115463184B (zh) | 一种具有促进睡眠功能的含益生菌组合物及其制备方法和应用 | |
| CN110664879B (zh) | 一种人参茎叶总皂苷阴道膨胀栓及其制备方法和应用 | |
| CN101049363A (zh) | 一种肤痒剂的药物组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220506 |
|
| RJ01 | Rejection of invention patent application after publication |